Dispassionate Reportorial

Keyword Search: FDA

Government Proposals Threaten Trans Youth Healthcare

The U.S. Department of Health and Human Services has proposed measures that could effectively ban gender-affirming medical care for transgender youth, amidst ongoing attacks on their rights and healthcare access... read more.

Concerns Over FDA Leadership and Vaccine Regulation Changes

Tracy Beth Høeg's appointment as acting director of the FDA's Center for Drug Evaluation and Research raises questions about her qualifications and the implications of proposed changes to vaccine regulations in the U.S... read more.

Federal Health Agency Restructuring Under Kennedy

Robert F. Kennedy Jr. has initiated significant personnel cuts at the U.S. Department of Health and Human Services, impacting thousands of employees and raising concerns about the future of public health initiatives... read more.

Concerns Over FDA Oversight and Public Health Risks

A recent Government Accountability Office report highlights the FDA's inadequate oversight of medical device recalls, raising significant public health concerns, particularly following the recall of Philips Respironics breathing machines linked to serious health risks... read more.

Senator Johnson Promotes Discredited Chlorine Dioxide Treatment Amid Public Health Concerns

Senator Ron Johnson has endorsed a controversial book promoting chlorine dioxide as a treatment for various conditions, including autism, despite widespread criticism from health experts and regulatory warnings about its safety... read more.

Concerns Over New FDA Drug Center Leadership

Tracy Beth Høeg is set to become the acting director of the FDA's Center for Drug Evaluation and Research, amid concerns from FDA staff regarding her potential bias in drug regulation... read more.

Concerns Over New FDA Drug Center Leadership

Tracy Beth Høeg is set to become the acting director of the FDA's Center for Drug Evaluation and Research, amid concerns from FDA staff regarding her potential bias in drug regulation... read more.

Concerns Raised Over FDA Leadership Change

The appointment of Dr. Tracy Beth Høeg as acting director of the FDA's Center for Drug Evaluation and Research has sparked significant concern among FDA officials regarding the agency's credibility and regulatory integrity... read more.